Psilocybin-Research.comSearchable psilocybin and psilocin bibliometrics.
Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

D'Amico E

107 indexed publications match this author name.

ORCID
Not found in stored metadata
OpenAlex
Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Publication history

Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headacheJournal of Psychopharmacology · 2026-05-28Prohedonic Effects of Psilocybin (COMP360) in a Touchscreen-Based Rodent Probabilistic Reward Task (Abstract ID: 227883)Journal of Pharmacology and Experimental Therapeutics · 2026-04-30PDE4B Inhibition and Psilocybin as Promising Approaches for Treating Methamphetamine Use Disorder: Preclinical Evidence From Rat Models (Abstract ID: 232554)Journal of Pharmacology and Experimental Therapeutics · 2026-04-30Effects of Psilocybin on Attentional Set-Shifting Following Chronic Unpredictable Stress in Rats (Abstract ID: 231339)Journal of Pharmacology and Experimental Therapeutics · 2026-04-301080 Psilocybin Elicits Non-Linear Night to Night Changes in Sleep Spectral PowerSLEEP · 2026-04-30Effects of Psilocybin and Select Pharmaceutical InteractionsMacEwan University Student eJournal · 2026-02-17Pharmacological Management of Anxiety in End-of-Life Care: A Systematic Review of Benzodiazepines, Opioids, and PsilocybinHuman Psychopharmacology Clinical and Experimental · 2025-12-31Psilocybin elicits a conserved glucocorticoid-responsive gene signature across five 5-HT2A receptor-rich brain regions in ratActa Neuropsychiatrica · 2025-12-31Exploring Determinants of Psilocybin Acceptance as an Alternative Modality for Major Depressive Disorder: A Pilot StudyJournal of Complementary and Alternative Medical Research · 2025-12-15Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trialTranslational Psychiatry · 2025-11-12Hormonal Influences on Psilocybin Responsivity Across the Female Lifespan: Toward Personalized Psychedelic-Assisted TherapyPsychoactives · 2025-11-01Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspringNature Communications · 2025-09-29Corrigendum to "Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder" [Neuropharmacology 279 (2025) 110648].Unknown journal · 2025-09-11Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreatFrontiers in Psychiatry · 2025-08-05Stronger visual surround suppression under psilocybin: A psychophysical and EEG pilot studyJournal of Vision · 2025-07-14Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge studyComprehensive Psychiatry · 2025-07-01Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprisesMolecular Psychiatry · 2025-04-25Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathwayNaunyn-Schmiedeberg s Archives of Pharmacology · 2025-04-14Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models.Unknown journal · 2025-04-01Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive DisorderThe Journal of Clinical Psychiatry · 2025-03-02Evaluating the Influence of CYP450 Enzyme Inducers on the Efficacy of Psilocybin as a Treatment for Neuropsychiatric Disorders (Abstract ID: 167358)Journal of Pharmacology and Experimental Therapeutics · 2025-02-28Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Unknown journal · 2025-01-29Study Protocol for ‘PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity’Cureus · 2025-01-28Effects of escitalopram and psilocybin therapy on mesolimbic resting-state functional connectivity in depressionNeuroscience Applied · 2024-12-31Psilocybin-Assisted Group Psychotherapy + Mindfulness Based Stress Reduction (MBSR) for Frontline Healthcare Provider COVID-19 Related Depression and Burnout: A Randomized Clinical TrialmedRxiv · 2024-12-31Psilocybin Fungi Unveiled: Morphological Characteristics and Pharmacological PotentialsInternational Journal for Research in Applied Science and Engineering Technology · 2024-11-16The Effect of Psilocybe cubensis on Spatial Memory and BDNF Expression in Male Rats Exposed to Chronic Unpredictable Mild StressJournal of Psychoactive Drugs · 2024-11-12Enhanced visual contrast suppression during peak psilocybin effects: Psychophysical results from a pilot randomized controlled trialJournal of Vision · 2024-11-04Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialEClinicalMedicine · 2024-09-22Acute Effects of Psilocybin and Salvinorin-A on Functional ConnectivityProceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2024-08-13Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapyScientific Reports · 2024-07-16Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action”Frontiers in Psychiatry · 2024-06-03The Classical Psychedelic Psilocybin Mitigates Oxycodone WithdrawalJournal of Pharmacology and Experimental Therapeutics · 2024-05-12Psilocybin-induced anxiolytic effects supported by transient elevation of corticosteroneJournal of Pharmacology and Experimental Therapeutics · 2024-05-12The selective 5-HT2A receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodentsbioRxiv · 2024-04-21Psilocybin reduces functional connectivity and the encoding of spatial information by neurons in mouse retrosplenial cortexAuthorea Preprints · 2024-04-21Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depressionJournal of Psychopharmacology · 2024-03-21Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive DisorderInternational Journal of Mental Health and Addiction · 2024-03-06Psychedelic Therapy: A Primer for Primary Care Clinicians-PsilocybinAmerican Journal of Therapeutics · 2024-02-29Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivityJournal of Affective Disorders · 2024-02-26The Temporal Trajectory of the Psychedelic Mushroom Experience Mimics the Narrative Arc of the Hero’s JourneyResearch Square · 2024-02-22Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.Unknown journal · 2024-02-15Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot studyScientific Reports · 2024-02-06Strong Bipartisan Support for Controlled Psilocybin Use as Treatment or Enhancement in a Representative Sample of US Americans: Need for Caution in Public Policy PersistsAJOB Neuroscience · 2024-02-04Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depressionPsychological Medicine · 2024-01-21Psilocybin vs Escitalopram for depression: 6-month follow-upNeuroscience Applied · 2023-12-31Effects of psilocybin and sleep quality on brain water diffusivity and microstructure in healthy individuals and chronic cluster headache patientsNeuroscience Applied · 2023-12-31Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiencesScientific Reports · 2023-08-21Distinctive Molecular and Metabolic Profiles of Chemically Synthesized Psilocybin and Psychedelic Mushroom ExtractResearch Square · 2023-07-19Personality change in a trial of psilocybin therapy v. escitalopram treatment for depressionPsychological Medicine · 2023-06-01A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depressionJournal of Psychopharmacology · 2023-04-24Acute neurovascular effects of psilocybin administration in healthy humans: Implications for cerebral blood flow measurements using arterial spin labellingNeuroscience Applied · 2022-12-31A multi-metric evaluation of psilocybin effects on functional brain entropy in healthy volunteersNeuroscience Applied · 2022-12-31Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up resultsNeuroscience Applied · 2022-12-31DNA Authentication and Chemical Analysis of Psilocybe Mushrooms Reveal Widespread Misdeterminations in Fungaria and Inconsistencies in MetabolitesApplied and Environmental Microbiology · 2022-11-28Body mass index (BMI) does not predict responses to psilocybin.Journal of Psychopharmacology · 2022-11-13Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.Psychedelic Medicine · 2022-10-27Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.BJPsych Open · 2022-09-05Neuroimaging in psychedelic drug development: Past, present, and futurePsyArXiv · 2022-06-29Psilocybin-induced takotsubo cardiomyopathy.BMJ Case Reports · 2022-05-16Increased global integration in the brain after psilocybin therapy for depression.Nature Medicine · 2022-04-10Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.Frontiers in Pharmacology · 2022-03-30Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report.Frontiers in Pharmacology · 2022-03-08Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulatory effects in healthy humansNeuroscience Applied · 2021-12-31Acute change in functional brain entropy following psilocybin administration in healthy volunteersNeuroscience Applied · 2021-12-31P.0593 Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individualsEuropean Neuropsychopharmacology · 2021-11-30P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot studyEuropean Neuropsychopharmacology · 2021-11-30P.0828 Psilocybin enhances emotional response to music in healthy individualsEuropean Neuropsychopharmacology · 2021-11-30Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".Frontiers in Psychiatry · 2021-10-19Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis.Unknown journal · 2021-09-13Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports.Pharmacopsychiatry · 2021-08-03Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.Journal of Psychopharmacology · 2021-06-29Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample.Frontiers in Psychiatry · 2021-06-28Trial of Psilocybin versus Escitalopram for Depression.New England Journal of Medicine · 2021-03-31Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reportsPsyArXiv · 2021-02-23Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humansJournal of Psychopharmacology · 2020-10-07The emerging role of psilocybin and MDMA in the treatment of mental illness.Unknown journal · 2020-09-29Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of PsilocybinACS Omega · 2020-06-30P.839 Modelling the acute temporal dynamics of psilocybin psychoactive effects; relation to brain serotonin 2a receptor levelsEuropean Neuropsychopharmacology · 2019-11-30Cessation and reduction in alcohol consumption and misuse after psychedelic use.Unknown journal · 2019-05-13Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levelsNeuropsychopharmacology · 2019-01-25Psilocybin occupancy of brain serotonin 2A receptors correlates with psilocin levels and subjective experience: a [11C]Cimbi-36 PET study in humansEuropean Neuropsychopharmacology · 2018-12-31d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.Unknown journal · 2018-08-30Effects of psilocybin therapy on personality structure.Acta Psychiatrica Scandinavica · 2018-06-18Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.Psychopharmacology · 2017-11-07Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.The Lancet Psychiatry · 2016-05-16Phylogenetic and chemical studies in the potential psychotropic species complex of Psilocybe atrobrunnea with taxonomic and nomenclatural notes.Persoonia - Molecular Phylogeny and Evolution of Fungi · 2014-10-20The Heffter Research Institute: past and hopeful future.Journal of Psychoactive Drugs · 2013-12-31Broadband cortical desynchronization underlies the human psychedelic state.Journal of Neuroscience · 2013-08-31Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis.Schizophrenia Bulletin · 2012-10-07Simultaneous polysubstance use among Danish 3,4-methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases.Human Psychopharmacology Clinical and Experimental · 2012-06-13Effects of the hallucinogenic drugs mescaline, phencyclidine and psilocybin on zebrafish behavior and physiologyThe FASEB Journal · 2012-03-31Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.The British Journal of Psychiatry · 2012-01-25Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.Proceedings of the National Academy of Sciences · 2012-01-22Iconography in Bradshaw rock art: breaking the circularity.Clinical and Experimental Optometry · 2011-08-31P.1.e.017 The functional brain correlates of the psychedelic state: an arterial spin labelling study with psilocybinEuropean Neuropsychopharmacology · 2011-08-06Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.Psychopharmacology · 2006-07-05Patterns of simultaneous polysubstance use in drug using university students.Human Psychopharmacology Clinical and Experimental · 2006-05-31ChemInform Abstract: Improvements to the Synthesis of Psilocybin and a Facile Method for Preparing the O-Acetyl Prodrug of Psilocin.ChemInform · 1999-08-16Improvements to the Synthesis of Psilocybin and a Facile Method for Preparing the O-Acetyl Prodrug of PsilocinSynthesis · 1999-05-31The genus psilocybeJournal of Ethnopharmacology · 1984-04-30Sequelae of a 'magic mushroom banquet'.Postgraduate medical journal · 1981-08-31ChemInform Abstract: COMPARISON OF SOLUTION CONFORMATIONAL PREFERENCES FOR THE HALLUCINOGENS BUFOTENIN AND PSILOCIN USING 360-MHZ PROTON NMR SPECTROSCOPYChemischer Informationsdienst · 1981-07-13Time contraction and psychomotor performance produced by "Psilocybin".Unknown journal · 1965-12-31THE IN VITRO INHIBITORY EFFECT OF PSILOCYBIN AND RELATED COMPOUNDS OF HUMAN CHOLINESTERASES.Unknown journal · 1963-04-30AN ELECTROGRAPHIC STUDY OF PSILOCIN AND4-METHYL-α-METHYL TRYPTAMINE (MP-809)The Journal of Pharmacology and Experimental Therapeutics · 1963-03-31

Author directory

Carhart-Harris RL.58 publicationsVollenweider FX51 publicationsCarhart-Harris R50 publicationsGriffiths RR50 publicationsNutt DJ49 publicationsJohnson MW44 publicationsErritzoe D42 publicationsRoseman L41 publicationsRobin Carhart-Harris39 publicationsBarrett FS.34 publicationsPreller KH33 publicationsJohns Hopkins University31 publicationsKnudsen GM30 publicationsNutt D28 publicationsHendricks PS27 publicationsDavid Erritzøe25 publicationsRoland R. Griffiths25 publicationsGarcia-Romeu A23 publicationsDavid Nutt22 publicationsFranz X. Vollenweider22 publicationsGitte M. Knudsen22 publicationsPáleníček T.22 publicationsRosenblat JD22 publicationsFisher PM21 publicationsDavis AK20 publicationsDea Siggaard Stenbæk19 publicationsKargbo RB.19 publicationsKatrin H. Preller19 publicationsMcIntyre RS.19 publicationsStenbæk DS19 publicationsTimmermann C19 publicationsDos Santos RG18 publicationsLiechti ME18 publicationsPatrick M. Fisher18 publicationsRoss S18 publicationsYaden DB18 publicationsDeco G17 publicationsDirk Hoffmeister17 publicationsHusain MI17 publicationsKuypers KPC.17 publicationsM. Madsen17 publicationsMatthew W. Johnson17 publicationsSimonsson O17 publicationsTomáš Páleníček17 publicationsKringelbach ML.16 publicationsOzenne B16 publicationsSeifritz E16 publicationsBrice Ozenne15 publicationsFischer R.15 publicationsFrederick S. Barrett15 publicationsGonzález-Maeso J15 publicationsGuy M. Goodwin15 publicationsJoshua D. Rosenblat15 publicationsKettner H15 publicationsKwan AC.15 publicationsMadsen MK15 publicationsMason NL.15 publicationsNichols DE15 publicationsRamaekers JG15 publicationsUniversity Hospital15 publicationsYale University15 publicationsAlbert Garcia-Romeu14 publicationsBogenschutz MP14 publicationsGeyer MA.14 publicationsHalberstadt AL14 publicationsKometer M14 publicationsNayak SM14 publicationsBasel13 publicationsFeilding A13 publicationsGukasyan N.13 publicationsManish Agrawal13 publicationsNathan D. Sepeda13 publicationsSandeep M. Nayak13 publicationsSwitzerland13 publicationsTagliazucchi E13 publicationsGiribaldi B12 publicationsGoldberg SB12 publicationsHallak JEC.12 publicationsHasler F.12 publicationsHoffmeister D12 publicationsJames Rucker12 publicationsLerer B.12 publicationsLiknaitzky P12 publicationsMcCulloch DE12 publicationsRucker J.12 publicationsRucker JJ.12 publicationsYoung AH12 publicationsAgin-Liebes G11 publicationsBenyamina A11 publicationsBouso JC.11 publicationsGouzoulis-Mayfrank E11 publicationsHolze F11 publicationsJoshua Woolley11 publicationsKaelen M11 publicationsMartin Kuchař11 publicationsMuhammad Ishrat Husain11 publicationsNichols CD.11 publicationsOsika W11 publicationsScott T. Aaronson11 publicationsStephen Ross11 publicationsWang X.11 publicationsAnderson BT10 publicationsBarnett BS10 publicationsDavoudian PA10 publicationsErica Kaczmarek10 publicationsHoráček J10 publicationsHouman Farzin10 publicationsKovar KA.10 publicationsMatthias E. Liechti10 publicationsMichael P. Bogenschutz10 publicationsRoger S. McIntyre10 publicationsSchmid Y10 publicationsSchoevers RA10 publicationsUniversity of California10 publicationsVohryzek J10 publicationsZoe Doyle10 publicationsAaronson ST9 publicationsAndrea Mattarei9 publicationsArmand S9 publicationsBotvinnik A9 publications